In addition, it has been suggested that P53 gene mutations trigger progression from differentiated to anaplastic carcinoma in human thyroid glands [51]; P53 is particularly hypermutable in thyroid cancer [52]. This evidence concerns the gene TP53 and thyroid cancer.